Athira Pharma, Inc.
ATHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$97 | -$118 | -$96 | -$55 |
| Dep. & Amort. | $0 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $11 | $0 | $5 |
| Change in WC | -$12 | $7 | $12 | $6 |
| Other Non-Cash | $0 | -$1 | $10 | $1 |
| Operating Cash Flow | -$97 | -$101 | -$72 | -$43 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$14 | -$28 | -$95 | -$299 |
| Inv. Sales/Matur. | $69 | $123 | $154 | $297 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $55 | $95 | $58 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $97 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $1 | $97 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$42 | -$5 | -$15 | $50 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $91 | $96 | $111 | $61 |
| End Cash | $49 | $91 | $96 | $111 |
| Free Cash Flow | -$97 | -$101 | -$74 | -$45 |